Aptadir Raises €40M Seed Round for Demethylation Pipeline
Aptadir raised €40M ($45M) in seed funding to advance first-in-class demethylating medicines. The Carroll County Mirror-Democrat report leaves investor names and disease targets undisclosed.
Topic
Aptadir
Topic
Aptadir
Aptadir pulls €40M seed round to reverse silenced genes
Aptadir has closed a €40M seed round to build technology that reverses silenced genes, Dealroom.co reports. Founders, lead invest…
Aptadir Lands €40M Seed to Build Demethylating Drug Pipeline
Aptadir raised a €40 million ($45 million) seed round to develop first-in-class demethylating medicines, in one of the larger see…